Terms: = Lymphoma AND FOXO1, Q12778, FOXO1A, 2308, ENSG00000150907, FKH1, FKHR
136 results:
1. Molecular Features of HHV8 Monoclonal Microlymphoma Associated with Kaposi Sarcoma and Multicentric Castleman Disease in an HIV-Negative Patient.
Rogges E; Pelliccia S; Savio C; Lopez G; Della Starza I; La Verde G; Di Napoli A
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612584
[TBL] [Abstract] [Full Text] [Related]
2. Mutant foxo1 controls an oncogenic network via enhancer accessibility.
Layden HM; Ellis JD; Bomber ML; Bartlett LN; Hiebert SW; Stengel KR
Cell Genom; 2024 Apr; 4(4):100537. PubMed ID: 38604128
[TBL] [Abstract] [Full Text] [Related]
3. foxo1 reshapes neutrophils to aggravate acute brain damage and promote late depression after traumatic brain injury.
Zhou M; Liu YW; He YH; Zhang JY; Guo H; Wang H; Ren JK; Su YX; Yang T; Li JB; He WH; Ma PJ; Mi MT; Dai SS
Mil Med Res; 2024 Mar; 11(1):20. PubMed ID: 38556884
[TBL] [Abstract] [Full Text] [Related]
4.
Yang L; Jiang X; Fu S; Tan J; Dian W; Zhou Y
Discov Med; 2024 Feb; 36(181):402-414. PubMed ID: 38409845
[TBL] [Abstract] [Full Text] [Related]
5. In vitro and in vivo anti-colorectal cancer effect of the newly synthesized sericin/propolis/fluorouracil nanoplatform through modulation of PI3K/AKT/mTOR pathway.
Diab SE; Tayea NA; Elwakil BH; Elshewemi SS; Gad AAEM; Abdulmalek SA; Ghareeb DA; Olama ZA
Sci Rep; 2024 Jan; 14(1):2433. PubMed ID: 38286826
[TBL] [Abstract] [Full Text] [Related]
6. Co-expression of regulatory B-cell markers, transforming growth factor β and interleukin-10 as a prognostic factor in diffuse large B-cell lymphoma.
Mishina T; Miyoshi H; Takeuchi M; Miyawaki K; Nakashima K; Yamada K; Moritsubo M; Inoue-Mitsuyama K; Shimasaki Y; Imamoto T; Kawamoto K; Furuta T; Kohno K; Kato K; Akashi K; Ohshima K
Pathol Res Pract; 2024 Feb; 254():155117. PubMed ID: 38262270
[TBL] [Abstract] [Full Text] [Related]
7. BPA and low-Se exacerbate apoptosis and autophagy in the chicken bursa of Fabricius by regulating the ROS/AKT/foxo1 pathway.
Sun W; Xu T; Lin H; Yin Y; Xu S
Sci Total Environ; 2024 Jan; 908():168424. PubMed ID: 37944606
[TBL] [Abstract] [Full Text] [Related]
8. Clinicopathologic and mutational profiles of primary breast diffuse large B cell lymphoma in a male patient: case report and literature review.
Huang F; Ruan Y; He X; Lian H; Yang J
World J Surg Oncol; 2023 Oct; 21(1):342. PubMed ID: 37884941
[TBL] [Abstract] [Full Text] [Related]
9. Down-regulation of Musashi-2 exerts antileukemic effects on acute lymphoblastic leukemia cells and increases sensitivity to dexamethasone.
Zou D; Lv M; Chen Y; Niu T; Ma C; Shi C; Huang Z; Wu Y; Yang S; Wang Y; Wu N; Zhang Y; Ouyang G; Mu Q
Ann Hematol; 2024 Jan; 103(1):141-151. PubMed ID: 37749318
[TBL] [Abstract] [Full Text] [Related]
10. Leukemic presentation and progressive genomic alterations of MCD/C5 diffuse large B-cell lymphoma (DLBCL).
Kim PM; Nejati R; Lu P; Thakkar D; Mackrides N; Dupoux V; Nakhoda S; Baldwin DA; Pei J; Dave SS; Wang YL; Wasik MA
Cold Spring Harb Mol Case Stud; 2023 Dec; 9(4):. PubMed ID: 37730436
[TBL] [Abstract] [Full Text] [Related]
11. Targeting FoxO proteins induces lytic reactivation of KSHV for treating herpesviral primary effusion lymphoma.
Lan J; Wang Y; Yue S; Xu D; Li Y; Peng X; Hu J; Ju E; He S; Li T
PLoS Pathog; 2023 Aug; 19(8):e1011581. PubMed ID: 37594999
[TBL] [Abstract] [Full Text] [Related]
12. Nicotinamide enhances natural killer cell function and yields remissions in patients with non-Hodgkin lymphoma.
Cichocki F; Zhang B; Wu CY; Chiu E; Day A; O'Connor RS; Yackoubov D; Simantov R; McKenna DH; Cao Q; Defor TE; Janakiram M; Wangen R; Cayci Z; Snyder N; Kumar A; Grzywacz B; Hwang J; Geffen Y; Miller JS; Maakaron J; Bachanova V
Sci Transl Med; 2023 Jul; 15(705):eade3341. PubMed ID: 37467318
[TBL] [Abstract] [Full Text] [Related]
13. PRMT5 inhibition drives therapeutic vulnerability to combination treatment with BCL-2 inhibition in mantle cell lymphoma.
Brown-Burke F; Hwang I; Sloan S; Hinterschied C; Helmig-Mason J; Long M; Chan WK; Prouty A; Chung JH; Zhang Y; Singh S; Youssef Y; Bhagwat N; Chen Z; Chen-Kiang S; Di Liberto M; Elemento O; Sehgal L; Alinari L; Vaddi K; Scherle P; Lapalombella R; Paik J; Baiocchi RA
Blood Adv; 2023 Oct; 7(20):6211-6224. PubMed ID: 37327122
[TBL] [Abstract] [Full Text] [Related]
14. The discrete roles of individual FOXO transcription factor family members in B-cell malignancies.
Lees J; Hay J; Moles MW; Michie AM
Front Immunol; 2023; 14():1179101. PubMed ID: 37275916
[TBL] [Abstract] [Full Text] [Related]
15. Genomic landscape of follicular lymphoma across a wide spectrum of clinical behaviors.
Mozas P; López C; Grau M; Nadeu F; Clot G; Valle S; Kulis M; Navarro A; Ramis-Zaldivar JE; González-Farré B; Rivas-Delgado A; Rivero A; Frigola G; Balagué O; Giné E; Delgado J; Villamor N; Matutes E; Magnano L; García-Sanz R; Huet S; Russell RB; Campo E; López-Guillermo A; Beà S
Hematol Oncol; 2023 Oct; 41(4):631-643. PubMed ID: 36994552
[TBL] [Abstract] [Full Text] [Related]
16. First Report of FARSA in the Regulation of Cell Cycle and Survival in Mantle Cell lymphoma Cells via PI3K-AKT and foxo1-RAG1 Axes.
Feng M; Yang K; Wang J; Li G; Zhang H
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675119
[TBL] [Abstract] [Full Text] [Related]
17. Disruption to the FOXO-PRDM1 axis resulting from deletions of chromosome 6 in acute lymphoblastic leukaemia.
Sinclair PB; Cranston RE; Raninga P; Cheng J; Hanna R; Hawking Z; Hair S; Ryan SL; Enshaei A; Nakjang S; Rand V; Blair HJ; Moorman AV; Heidenreich O; Harrison CJ
Leukemia; 2023 Mar; 37(3):636-649. PubMed ID: 36670235
[TBL] [Abstract] [Full Text] [Related]
18. Diffuse large B-cell lymphoma and red cell autoimmunity: clinical role and pathogenesis.
Coombes C; Horikawa K; Jain S; Jiang S; Lim JH; Saxena K; Shadbolt B; Smyth L; Tobin J; Talaulikar D
Pathology; 2023 Feb; 55(1):104-112. PubMed ID: 36420560
[TBL] [Abstract] [Full Text] [Related]
19. A foxo1-dependent transcription network is a targetable vulnerability of mantle cell lymphomas.
Jang JY; Hwang I; Pan H; Yao J; Alinari L; Imada E; Zanettini C; Kluk MJ; Wang Y; Lee Y; Lin HV; Huang X; Di Liberto M; Chen Z; Ballman KV; Cantley LC; Marchionni L; Inghirami G; Elemento O; Baiocchi RA; Chen-Kiang S; Belvedere S; Zheng H; Paik J
J Clin Invest; 2022 Dec; 132(24):. PubMed ID: 36282572
[TBL] [Abstract] [Full Text] [Related]
20. Inhibition of acylglycerol kinase sensitizes DLBCL to venetoclax via upregulation of foxo1-mediated BCL-2 expression.
Ning N; Zhang S; Wu Q; Li X; Kuang D; Duan Y; Xia M; Liu H; Weng J; Ba H; Tang Z; Cheng X; Mei H; Huang L; Ao Q; Wang G; Hu Y; Laurence A; Wang J; Wang G; Yang XP
Theranostics; 2022; 12(12):5537-5550. PubMed ID: 35910796
[No Abstract] [Full Text] [Related]
[Next]
